Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Labelle

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Journal of Clinical Psychopharmacology|January 26, 2026
Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia: A Randomized Open-Label TrialNaista Zhand, Ridha Joober, Alain Labelle, et al.
Neuroscience Letters|February 22, 2015
Effects of acute CDP-choline treatment on resting state brain oscillations in healthy volunteersVerner Knott, Sara de la Salle, Dylan Smith, et al.
Pharmacology, Biochemistry, and Behavior|February 15, 2015
Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteersVerner Knott, Sara de la Salle, Joelle Choueiry, et al.
Schizophrenia Research|December 12, 2001
Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteersRidha Joober, Guy A Rouleau, Samarthji Lal, et al.
BMC Genetics|June 6, 2006
Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophreniaSarojini Sengupta, Lan Xiong, Ferid Fathalli, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 30, 2003
Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association studyKenji Yamamoto, Joseph F Cubells, Joel Gelernter, et al.
Neuropsychiatric Disease and Treatment|June 24, 2008
Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disordersStan Kutcher, Sarah J Brooks, David M Gardner, et al.
Brain Research. Molecular Brain Research|January 22, 2005
CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophreniaLan Xiong, Guy A Rouleau, Lynn E Delisi, et al.
Annals of General Psychiatry|January 26, 2013
Evidence review and clinical guidance for the use of ziprasidone in CanadaDavid M Gardner, Andrea L Murphy, Stan Kutcher, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Clinical Psychopharmacology|January 26, 2026
Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia: A Randomized Open-Label TrialNaista Zhand, Ridha Joober, Alain Labelle, et al.
Neuroscience Letters|February 22, 2015
Effects of acute CDP-choline treatment on resting state brain oscillations in healthy volunteersVerner Knott, Sara de la Salle, Dylan Smith, et al.
Pharmacology, Biochemistry, and Behavior|February 15, 2015
Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteersVerner Knott, Sara de la Salle, Joelle Choueiry, et al.
Schizophrenia Research|December 12, 2001
Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteersRidha Joober, Guy A Rouleau, Samarthji Lal, et al.
BMC Genetics|June 6, 2006
Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophreniaSarojini Sengupta, Lan Xiong, Ferid Fathalli, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 30, 2003
Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association studyKenji Yamamoto, Joseph F Cubells, Joel Gelernter, et al.
Neuropsychiatric Disease and Treatment|June 24, 2008
Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disordersStan Kutcher, Sarah J Brooks, David M Gardner, et al.
Brain Research. Molecular Brain Research|January 22, 2005
CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophreniaLan Xiong, Guy A Rouleau, Lynn E Delisi, et al.
Annals of General Psychiatry|January 26, 2013
Evidence review and clinical guidance for the use of ziprasidone in CanadaDavid M Gardner, Andrea L Murphy, Stan Kutcher, et al.
Pageof 5